JP2025501056A5 - - Google Patents

Info

Publication number
JP2025501056A5
JP2025501056A5 JP2024529408A JP2024529408A JP2025501056A5 JP 2025501056 A5 JP2025501056 A5 JP 2025501056A5 JP 2024529408 A JP2024529408 A JP 2024529408A JP 2024529408 A JP2024529408 A JP 2024529408A JP 2025501056 A5 JP2025501056 A5 JP 2025501056A5
Authority
JP
Japan
Prior art keywords
group
groups
alkyl
cyano
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529408A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501056A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/143665 external-priority patent/WO2023125877A1/zh
Publication of JP2025501056A publication Critical patent/JP2025501056A/ja
Publication of JP2025501056A5 publication Critical patent/JP2025501056A5/ja
Pending legal-status Critical Current

Links

JP2024529408A 2021-12-30 2022-12-29 三環系誘導体阻害剤、その製造方法と応用 Pending JP2025501056A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202111655759.X 2021-12-30
CN202111655759 2021-12-30
CN202210249052 2022-03-14
CN202210249052.7 2022-03-14
CN202211064934 2022-08-31
CN202211064934.2 2022-08-31
PCT/CN2022/143665 WO2023125877A1 (zh) 2021-12-30 2022-12-29 三并环类衍生物抑制剂、其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2025501056A JP2025501056A (ja) 2025-01-17
JP2025501056A5 true JP2025501056A5 (https=) 2026-01-07

Family

ID=86998069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529408A Pending JP2025501056A (ja) 2021-12-30 2022-12-29 三環系誘導体阻害剤、その製造方法と応用

Country Status (11)

Country Link
US (1) US20250059196A1 (https=)
EP (1) EP4458819A4 (https=)
JP (1) JP2025501056A (https=)
KR (1) KR20240130085A (https=)
CN (1) CN118451068A (https=)
AU (1) AU2022425324A1 (https=)
CA (1) CA3242194A1 (https=)
IL (1) IL313925A (https=)
MX (1) MX2024008008A (https=)
TW (1) TW202333682A (https=)
WO (1) WO2023125877A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202515550A (zh) * 2023-06-29 2025-04-16 大陸商上海翰森生物醫藥科技有限公司 三并環類抑制劑與抗癌劑在製備抗腫瘤藥物中的聯合應用
CN121285553A (zh) * 2023-06-29 2026-01-06 上海翰森生物医药科技有限公司 一种三并环类衍生物抑制剂的晶型及其制备方法
CN117534669A (zh) * 2023-11-01 2024-02-09 上海凌凯医药科技有限公司 五元氮杂环并吡啶醇的制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667303B1 (en) 2001-07-30 2003-12-23 Wyeth Aryl substituted 1,4-diazepanes and method of use thereof
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
CN104884448A (zh) 2012-10-16 2015-09-02 詹森药业有限公司 Rorγt的杂芳基连接的喹啉基调节剂
EA201590916A1 (ru) 2012-11-09 2016-02-29 Корнэлл Юниверсити Низкомолекулярные ингибиторы malt1
SG11201607895PA (en) 2014-05-28 2016-12-29 Novartis Ag Novel pyrazolo pyrimidine derivatives and their use as malt1 inhibitors
US9812645B2 (en) 2015-02-13 2017-11-07 Flexterra, Inc. Perylene-based semiconductors
WO2017057695A1 (ja) 2015-09-30 2017-04-06 東レ株式会社 ジフェニルピラゾール誘導体及びその医薬用途
AU2016352813B2 (en) 2015-11-13 2019-09-19 Novartis Ag Novel pyrazolo pyrimidine derivatives
US10662156B2 (en) 2016-07-29 2020-05-26 Toray Industries, Inc. Guanidine derivative and medical use thereof
PE20190656A1 (es) 2016-07-29 2019-05-08 Lupin Ltd Compuestos de tiazolo-piridina sustituida como inhibidores de malt1
US10689366B2 (en) 2016-11-01 2020-06-23 Cornell University Compounds for MALT1 degredation
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為malt1抑制劑之吡唑衍生物
WO2018159650A1 (ja) 2017-02-28 2018-09-07 東レ株式会社 グアニジン誘導体及びその医薬用途
WO2018165385A1 (en) 2017-03-08 2018-09-13 Cornell University Inhibitors of malt1 and uses thereof
WO2018226150A1 (en) 2017-06-05 2018-12-13 Medivir Aktiebolag Pyrazolopyrimidine as malt-1 inhibitors
JPWO2019039429A1 (ja) 2017-08-22 2020-07-30 日本曹達株式会社 環状アミン化合物および有害生物防除剤
AU2019289222B2 (en) * 2018-06-18 2023-07-13 Janssen Pharmaceutica Nv Pyrazole derivatives as MALT1 inhibitors
EP3810609B1 (en) * 2018-06-18 2024-06-12 Janssen Pharmaceutica NV Pyrazole derivatives as malt1 inhibitors
KR20210069079A (ko) 2018-09-28 2021-06-10 얀센 파마슈티카 엔.브이. 모노아실글리세롤 리파아제 조절제
TWI848400B (zh) 2018-11-28 2024-07-11 日商武田藥品工業股份有限公司 雜環化合物及醫藥
CN109665987B (zh) * 2018-12-28 2022-02-18 河南大学 萘内酰亚胺-多胺缀合物及其制备方法和用途
US20220175760A1 (en) * 2019-02-22 2022-06-09 Janssen Pharmaceutica Nv Pharmaceutical formulations
EP3953345B1 (en) 2019-04-11 2023-04-05 Janssen Pharmaceutica NV Pyridine rings containing derivatives as malt1 inhibitors
TW202106684A (zh) 2019-05-03 2021-02-16 美商奇奈特生物製藥公司 Raf激酶抑制劑
CN112125885B (zh) * 2019-06-25 2026-03-17 中国药科大学 苯并吲哚类双功能分子衍生物及其应用
CN116723839A (zh) 2020-10-14 2023-09-08 C4医药公司 用于降解靶蛋白质的三环杂双官能化合物
CA3194351A1 (en) 2020-10-14 2022-04-21 Christopher G. Nasveschuk Tricyclic compounds to degrade neosubstrates for medical therapy
WO2022089406A1 (zh) 2020-10-26 2022-05-05 上海青煜医药科技有限公司 含氮稠杂环类化合物及其制备方法和应用
CN114907358A (zh) * 2021-02-09 2022-08-16 上海翰森生物医药科技有限公司 含吡啶多环类衍生物调节剂、其制备方法和应用
BR112023017689A2 (pt) * 2021-03-03 2023-11-14 Janssen Pharmaceutica Nv Método de tratamento de uma condição com o uso de uma dose terapeuticamente eficaz do inibidor de malt1 jnj-67856633 (1-(1-oxo-1,2-di-hidroisoquinolin-5-il)-5-(trifluorometil)-n­(2-(trifluorometil)piridin-4-il)-1h-pirazol-4-carboxamida)
TW202317537A (zh) * 2021-06-18 2023-05-01 大陸商上海拓界生物醫藥科技有限公司 一種malt 1抑制劑及其製備方法和用途

Similar Documents

Publication Publication Date Title
JP2025501056A5 (https=)
AU2021414253B2 (en) Series of piperidine-substituted benzoic acid compounds, and use thereof
JP7489381B2 (ja) Il-12、il-23および/またはifnアルファの調節に関連する疾患を治療するためのアミド置換ヘテロ環化合物
AU2019272481B2 (en) 2,3-dihydro-1H-pyrrolizine-7-formamide derivative and application thereof
JP2021532124A (ja) Nlrp3インフラマソーム阻害剤
JP7025414B2 (ja) Trpv4拮抗薬
US8354436B2 (en) IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
IL267215B (en) Imidazopyrrolopyridine as inhibitors of the jak family of kinases
JP2022535093A5 (https=)
JP2020530446A (ja) 化合物、組成物、及び、方法
CN105358546B (zh) 用作激酶抑制剂的经取代的四氢咔唑及咔唑甲酰胺化合物
RU2003105805A (ru) Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1
JP2022540890A5 (https=)
JP2024529527A5 (https=)
US20170008905A1 (en) Cot modulators and methods of use thereof
HK1248235A1 (zh) 具有作为吲哚胺2,3-二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物
JP2006514960A5 (https=)
TW201522339A (zh) P2x7調控劑
JP2019512535A (ja) Tnf活性のモジュレーターとしての縮合五環式イミダゾール誘導体
WO2019137201A1 (zh) 杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
JP2006517976A5 (https=)
CN103298807A (zh) 作为用于治疗自身免疫性疾病和血管疾病的s1p1激动剂的杂环化合物
TW202539672A (zh) 嘧啶并大環類kras抑制劑
WO2021237121A1 (en) Substituted pyridines
CN103119038A (zh) 作为1-磷酸鞘氨醇1受体激动剂的4-(5-异噁唑基或5-吡唑基-1,2,4-噁二唑基-3-基)扁桃酰胺